-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… agents, including cyclophosphamide, oxaliplatin, epirubicin, and … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer … small cell lung cancer patients. Lung Cancer. 2011;72 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
4 Causes of Hearing Problems for Cancer Survivors
16 Jul 2025 20:08 GMT
… medicines include cisplatin, carboplatin, and oxaliplatin. These medicines are commonly used … neck cancer, ovarian cancer, and lung cancer. Temporary or permanent hearing changes …
-
FDA’s Published CRLs Deliver Insight Into the Drug Approval Process
16 Jul 2025 17:44 GMT
… breast cancer, non–small cell lung cancer (NSCLC), and pancreatic cancer.11 … with fluoropyrimidine-irinotecan– or fluoropyrimidine-oxaliplatin–based chemotherapy following progression on …
-
Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers
16 Jul 2025 17:16 GMT
… for relapsed small cell lung cancer (SCLC) whereas emerging … extramedullary disease.14,15
Lung Cancer
Tarlatamab Significantly Improves … NSCLC Treatment Landscape
Lung cancer research has been … (Camptosar; Pfizer), and oxaliplatin, both of which demonstrated …
-
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02 Jun 2025 16:00 GMT
… and Non-Small Cell Lung Cancer
Two presentations at the … results at ASCO. In lung cancer, patient recruitment is progressing … metastatic non-small cell lung cancer and secondary resistance to … acid, fluorouracil, irinotecan and oxaliplatin
3 Trends in the …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Molecular Subtyping of Hepatocellular Carcinoma via Lysosome-Related Genes for Prognosis and Therapy Prediction
15 Jul 2025 21:34 GMT
… patients with non-small cell lung cancer.82 In addition, classical Cytotoxic … I-III non-small-cell lung cancer and its correlation with PD … , multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… and MPR.
About Lung Cancer
Lung cancer is the leading cause … treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.
OPDIVO® … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
About
© 1995-2025